<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>VitaForge - Home</title>
    
    <link rel="stylesheet" href="style.css">
    <link rel="stylesheet" href="home.css">
    <script src="auth.js"></script>

    <link rel="icon" href="favicon.ico">
</head>
<body>

    <nav class="navbar">
        <a href="index.html" class="nav-link active">Home</a>
        <a href="investors.html" class="nav-link">Investors</a>
        <a href="dashboard.html" class="nav-link">Asset Dashboard</a>
        <a href="treasury.html" class="nav-link">Bitcoin Treasury</a>
    </nav>

    <div class="hero">
        <img src="VitaForge_Logo.png" alt="VitaForge Logo" class="hero-logo">
        
        <h1>Biotech, De-Risked.<br>Liquidity, Unlocked.</h1>
        
        <p class="subtitle">
            VitaForge is a capital-efficient NRDO fusing rigorous clinical development with a high-yield Bitcoin treasury. 
            We replace the 10-year lockup with tokenized liquidity and precision financing.
        </p>
    </div>

    <div class="content-section">
        <div class="grid-3">
            <div class="value-card">
                <div class="value-title">Liquid Investment</div>
                <div class="value-text">
                    Our tokenized framework offers investors optionality to exit after early milestones, 
                    eliminating the illiquidity trap of traditional biotech.
                </div>
            </div>
            <div class="value-card">
                <div class="value-title">Precision De-Risking</div>
                <div class="value-text">
                    Fundraising is scaled strictly to critical execution steps—from GLP Tox to Phase 2—maximizing 
                    capital efficiency and minimizing dilution.
                </div>
            </div>
            <div class="value-card">
                <div class="value-title">Bitcoin Treasury 2.0</div>
                <div class="value-text">
                    We harness clinical volatility to issue convertible notes, channeling proceeds into a segregated 
                    Bitcoin treasury—not biotech operations.
                </div>
            </div>
        </div>

        <div class="explainer-container">
            <div class="explainer-item">
                <div class="explainer-label">The Engine</div>
                <div class="explainer-desc">
                    We eliminate platform risk by treating every clinical program as a standalone 
                    entity with its own milestone-based fundraising. Investors fund specific assets, 
                    not a diluted pipeline.
                </div>
            </div>
            <div class="explainer-item">
                <div class="explainer-label">The Fuel</div>
                <div class="explainer-desc">
                    As the platform operator, VitaForge harnesses the volatility of these clinical 
                    programs to issue convertible notes. This allows us to fund a corporate Bitcoin 
                    treasury without touching the segregated clinical funds.
                </div>
            </div>
            <div class="explainer-item">
                <div class="explainer-label">The Exit</div>
                <div class="explainer-desc">
                    Tokenization allows for asset-specific exits. Investors gain liquidity upon individual 
                    successful milestones, while partners can license single, de-risked assets without 
                    complex entanglements.
                </div>
            </div>
        </div>

        <div class="cta-container">
            <a href="dashboard.html" class="cta-btn">View Portfolio</a>
        </div>
    </div>

</body>
</html>
